Jackson State University will helm the Enrich initiative to engage health innovators from 25 historically-black US colleges and universities.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

T1 Esports, HP Tech Ventures and Axiomatic have all invested in an $11.3m round for the company, which plans to now enhance its esports performance analysis system.

UC Berkeley's genetic drug developer 4DMT has pulled away from a proposed $100m offering after closing series C funding last month.

Sumitomo's Presidio Ventures unit has contributed to the $56.2m in debt and equity financing so far raised by the robot arm developer.

Vesigen has attracted Leaps by Bayer to commercialise drug delivery technology invented by Quan Lu at Harvard School of Public Health.

GV had led an oversubscribed series D round for the gene therapy developer that also featured Illumina Ventures and SoftBank Vision Fund II.

Dexterity, a logistics robot spinout of Stanford, has emerged from stealth with series A funding and debt financing from Stanford-StartX Fund.

Pfizer and Chiesi-backed genetic drug developer 4DMT has pulled away from a proposed $100m offering after closing series C funding last month.

Existing investor Unilever Ventures returned for the marketing management platform developer's latest round, following its series B a year ago.